Aishwarya Reddy
Aishwarya Reddy has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Dheeraj Nagpal
Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University, Sector 125, Noida-201303, India
1 shared publication - Shikha Saxena
Amity Institute of Pharmacy, Amity University, Noida, India
1 shared publication
Latest Publications
- Open Access
- 31 October 2024
- Published by Oriental Scientific Publishing Company in Oriental Journal of Chemistry
- Vol. 40 (5) , 1415-1425
A Six Sigma Approach to Pharmaceutical Industry- A Better Insight
Six Sigma is a statistical method assists in systemic issue definition, offers tools for monitoring and analysing influencing elements, and suggests changes that are simple to execute. The present study set out to investigate how the pharmaceutical industry's performance changed because of applying six sigma and its methodology demands a strong commitment from top management as well as appropriate training for vital people, also known to as champions and black belts. The article discusses the impact that Six Sigma implementation has on the operations of the pharmaceutical industry and highlights the advantages that organisations as well as consumers might experience because of the findings while also conducting a comparative analysis of the performance of the pharmaceutical industry across various International Organization, before and after the implementation of the methodology. According to the study's outcomes, the performance of the pharmaceutical business is significantly and beneficially impacted by the 6 𝜎 approach.
- 31 October 2024
- Published by Oriental Scientific Publishing Company in Oriental Journal of Chemistry
- Vol. 40 (5) , 1415-1425
Open AccessA Six Sigma Approach to Pharmaceutical Industry- A Better Insight
Six Sigma is a statistical method assists in systemic issue definition, offers tools for monitoring and analysing influencing elements, and suggests changes that are simple to execute. The present study set out to investigate how the pharmaceutical industry's performance changed because of applying six sigma and its methodology demands a strong commitment from top management as well as appropriate training for vital people, also known to as champions and black belts. The article discusses the impact that Six Sigma implementation has on the operations of the pharmaceutical industry and highlights the advantages that organisations as well as consumers might experience because of the findings while also conducting a comparative analysis of the performance of the pharmaceutical industry across various International Organization, before and after the implementation of the methodology. According to the study's outcomes, the performance of the pharmaceutical business is significantly and beneficially impacted by the 6 𝜎 approach.